Sarepta Therapeutics, Inc 10-Q for FY2026 Q2
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2026-08-05
For: 2026-06-30
View Original
Added on
August 05, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $401.25M
- down 34.3% from $611.09M a year earlier
- Net loss
- $4.89M
- compared with net income of $196.89M a year earlier
- Diluted EPS
- -$0.05
- compared with $1.89 a year earlier